Daratumumab-lenalidomide and the immunosuppressive budget in myeloma - Authors' reply.
Saved in:
| Title: | Daratumumab-lenalidomide and the immunosuppressive budget in myeloma - Authors' reply. |
|---|---|
| Authors: | Manier S; Department of Hematology, University Hospital of Lille, INSERM UMR-S1277, Lille, France. Electronic address: salomon.manier@chu-lille.fr., Lambert J; Department of Biostatistics and Epidemiology, University Hospital Saint-Louis, Paris, France., Hulin C; Department of Hematology, University Hospital of Bordeaux, Bordeaux, France., Macro M; Department of Hematology, University Hospital of Caen Normandie, Caen, France., Leleu X; Department of Hematology, University Hospital of Poitiers, Poitiers, France., Facon T; Department of Hematology, University Hospital of Lille, INSERM UMR-S1277, Lille, France. |
| Source: | The Lancet. Oncology [Lancet Oncol] 2026 Feb; Vol. 27 (2), pp. e65. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| ISSN: | 1474-5488 |
|---|---|
| DOI: | 10.1016/S1470-2045(26)00019-7 |
